#EACS 2019

Gilead’s HIV capsid inhibitor might need dosing only every six months

Abnormal anal screening results are common, but they often do not to lead to invasive cancer.

Future research should examine how particular combinations of antiretrovirals contribute to weight gain, according to one expert.

Rates of HIV acquisition were very low among people taking Descovy or Truvada, but Descovy had less effect on kidneys and bones.

Studies indicate that there is a very low likelihood that people with HIV have preexisting resistance to the medication.

The integrase inhibitor–based HIV regimen was compared with dolutegravir-based regimens.